A multitarget ruthenium-clotrimazole complex eradicates MRSA through membrane disruption, DNA intercalation, and ROS generation
Bioorganic Chemistry · 2026-09 · 180 · 110249
DOI: 10.1016/j.bioorg.2026.110249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Xiaoyin Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Chemical Engineering, South China Agricultural Un…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Ruthenium, Anti-Bacterial Agents, Clotrimazole. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
The escalating crisis of antibiotic resistance necessitates the development of agents with novel mechanisms. In this work, three novel ruthenium(II) complexes coordinated with imidazole-based ligands were reported. Among them, Ru-ctz demonstrated exceptional activity against methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 0.78 μM, greatly surpassing clotrimazole (MIC = 50 μM), and exceeding both vancomycin (MIC = 1.56 μM) and daptomycin (MIC = 3.12 μM). Mechanistic investigations revealed a synergistic multitarget action: Ru-ctz disrupts bacterial membrane integrity, induces lethal reactive oxygen species (ROS), and intercalates into genomic DNA. It also potently inhibits and eradicates biofilms while suppressing the virulence factor α-hemolysin. Notably, Ru-ctz demonstrated a minimal propensity for resistance development over 20 serial passages. Furthermore, in a murine MRSA skin infection model, Ru-ctz effectively accelerated wound healing and mitigated inflammation, showing good biocompatibility. With its multitarget mechanism, compelling in vitro and in vivo efficacy, and low resistance propensity, Ru-ctz is positioned as a promising therapeutic candidate for combating multidrug-resistant bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Chemical Engineering, South China Agricultural University, Guangzhou 510642, China.
- College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
- College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China. Electronic address: panzhengyin@sztu.edu.cn.
- Key Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Chemical Engineering, South China Agricultural University, Guangzhou 510642, China. Electronic address: heliang@scau.ed…
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Wu, X., Li, J., Lei, W., Fu, B., Shao, J., Wang, Z., Huang, S., Chen, S., Liu, Y., Hou, J., Pan, Z., & He, L. (2026). A multitarget ruthenium-clotrimazole complex eradicates MRSA through membrane disruption, DNA intercalation, and ROS generation. Bioorganic Chemistry, 180, 110249. https://doi.org/10.1016/j.bioorg.2026.110249
Vancouver
Wu X, Li J, Lei W, Fu B, Shao J, Wang Z, et al. A multitarget ruthenium-clotrimazole complex eradicates MRSA through membrane disruption, DNA intercalation, and ROS generation. Bioorganic Chemistry. 2026;180:110249. doi:10.1016/j.bioorg.2026.110249
BibTeX
@article{Wu2026,
author = {Wu, Xiaoyin and Li, Jinhao and Lei, Wentao and Fu, Binbin and Shao, Jianping and Wang, Zifei and Huang, Sijia and Chen, Shuqi and Liu, Yashu and Hou, Jinhong and Pan, Zhengyin and He, Liang},
title = {A multitarget ruthenium-clotrimazole complex eradicates MRSA through membrane disruption, DNA intercalation, and ROS generation},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {180},
pages = {110249},
doi = {10.1016/j.bioorg.2026.110249}
}
EUVIMED